Hi-Tech announces FDA approval of its generic Penlac

AMITYVILLE, N.Y. Hi-Tech Pharmaceuticals has received final approval from the Food and Drug Administration for its application for the generic version of Dermik Laboratories’ topical nail fungus treatment drug Penlac.

Hi-Tech is a specialty pharmaceutical company that develops, manufactures, and markets brand and generic prescriptions and over-the-counter products for the healthcare industry.

Penlac had sales of $87 million in 2006, according to IMS sales data.